Электронный архив

Severe bronchial asthma patient care organization in various regions of the Russian Federation. From endotypes and phenotypes of bronchial asthma to personalized choice of therapy

Показать сокращенную информацию

dc.contributor.author Avdeev S.N.
dc.contributor.author Volkova O.A.
dc.contributor.author Demko I.V.
dc.contributor.author Ignatova G.L.
dc.contributor.author Leshchenko I.V.
dc.contributor.author Kanukova N.A.
dc.contributor.author Kudelya L.M.
dc.contributor.author Nevzorova V.A.
dc.contributor.author Nedashkovskaya N.G.
dc.contributor.author Ukhanova O.P.
dc.contributor.author Shulzhenko L.V.
dc.contributor.author Fassakhov R.S.
dc.date.accessioned 2021-02-25T20:33:13Z
dc.date.available 2021-02-25T20:33:13Z
dc.date.issued 2020
dc.identifier.issn 0040-3660
dc.identifier.uri https://dspace.kpfu.ru/xmlui/handle/net/161693
dc.description.abstract © 2020 Consilium Medikum. All rights reserved. The meeting of the Expert board was held in Moscow on June 24, 2019, at which the following issues were considered: the applicability of a new terminology characterizing asthma endotypes and phenotypes in real clinical practice, the effect of phenotypes and biomarkers in patients with bronchial asthma on the choice of biological drug, as well as the optimal clinical profiles of patients for whom dupilumab is most effective, taking into account the data of the III phase clinical trials, regional features of medical care and changes in updated international clinical guidelines for the diagnosis and treatment of asthma. The Expert board included members of leading Russian scientific and educational medical institutions: S.N. Avdeev, corresponding member of the Russian Academy of Sciences, prof., MD; O.A. Volkova, Ph.D.; I.V. Demko, prof., MD; G.L. Ignatova, prof., MD; I.V. Leshchenko, prof., MD; Kanukova N.A.; Kudelya L.M., prof., MD; V.A. Nevzorova, prof., MD; N.G. Nedashkovskaya; O.P. Ukhanova, prof., MD; L.V. Shulzhenko, prof., MD; R.S. Fassakhov, prof., MD.
dc.relation.ispartofseries Terapevticheskii Arkhiv
dc.subject Benilizumab
dc.subject Biological therapy of bronchial asthma
dc.subject Dupilumab
dc.subject Endotype
dc.subject Mepolizumab
dc.subject Omalizumab
dc.subject Phenotype
dc.subject Resilizumab
dc.subject Severe bronchial asthma
dc.subject T2-bronchial asthma
dc.title Severe bronchial asthma patient care organization in various regions of the Russian Federation. From endotypes and phenotypes of bronchial asthma to personalized choice of therapy
dc.type Article
dc.relation.ispartofseries-issue 2
dc.relation.ispartofseries-volume 92
dc.collection Публикации сотрудников КФУ
dc.relation.startpage 119
dc.source.id SCOPUS00403660-2020-92-2-SID85085101902


Файлы в этом документе

Данный элемент включен в следующие коллекции

  • Публикации сотрудников КФУ Scopus [24551]
    Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.

Показать сокращенную информацию

Поиск в электронном архиве


Расширенный поиск

Просмотр

Моя учетная запись

Статистика